Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company -- Ignore unavailable to you. Want to Upgrade?

To: Alfred W. Post who wrote (32)	1/12/2003 7:24:40 PM
From: Mike	Read Replies (1) \| Respond to of 125

First I would like to try to revive the board here. MDCO has delivered and has hit a homerun with the Replace 2 data. All primary and secondary endpoints of the trial were met. Sales for '02 ended with a high note. Earnings are released in early Feb. Sales for '02 will be in the $38M range. From the sources that I have in the field it has been estimated that November '02 were a record of approx $4M. The sales for Dec '02 were in the range of $5M. Projections have been made for '03 during the conference listed below. mapdigital.com During this conference the company stated that sales for '03 would be in the $70-$90M range. I think that this company is a "diamond in the rough". It is followed by very few analyst and needs more exposure. I think longs will be rewarded handsomely if the company executes. Mike